Physicians Realty Trust (NYSE:DOC) Director Tommy G. Thompson purchased 2,100 shares of the stock in a transaction on Wednesday, November 23rd. The shares were acquired at an average price of $18.05 per share, for a total transaction of $37,905.00. Following the transaction, the director now directly owns 32,938 shares of the company’s stock, valued at approximately $594,530.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Shares of Physicians Realty Trust (NYSE:DOC) opened at 18.53 on Wednesday. The stock has a 50 day moving average price of $19.10 and a 200-day moving average price of $20.23. Physicians Realty Trust has a 52 week low of $15.41 and a 52 week high of $22.03. The firm has a market capitalization of $2.49 billion, a PE ratio of 84.61 and a beta of 0.63.

Physicians Realty Trust (NYSE:DOC) last released its quarterly earnings results on Wednesday, November 2nd. The real estate investment trust reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by $0.01. The firm earned $70 million during the quarter, compared to analyst estimates of $66.21 million. Physicians Realty Trust had a return on equity of 1.77% and a net margin of 12.86%. The business’s revenue was up 100.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.26 EPS. Equities analysts anticipate that Physicians Realty Trust will post $1.01 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This news story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of United States and international copyright and trademark law. The original version of this news story can be read at https://www.thecerbatgem.com/2016/11/30/tommy-g-thompson-buys-2100-shares-of-physicians-realty-trust-doc-stock-2.html.

Several large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Physicians Realty Trust by 43.4% in the second quarter. Vanguard Group Inc. now owns 19,970,571 shares of the real estate investment trust’s stock worth $419,582,000 after buying an additional 6,039,827 shares in the last quarter. Cohen & Steers Inc. raised its stake in Physicians Realty Trust by 88.4% in the second quarter. Cohen & Steers Inc. now owns 12,532,933 shares of the real estate investment trust’s stock worth $263,317,000 after buying an additional 5,881,209 shares during the last quarter. Principal Financial Group Inc. raised its stake in Physicians Realty Trust by 8.2% in the third quarter. Principal Financial Group Inc. now owns 7,035,722 shares of the real estate investment trust’s stock worth $151,550,000 after buying an additional 531,308 shares during the last quarter. Brookfield Asset Management Inc. raised its stake in Physicians Realty Trust by 34.8% in the second quarter. Brookfield Asset Management Inc. now owns 4,613,225 shares of the real estate investment trust’s stock worth $96,924,000 after buying an additional 1,190,312 shares during the last quarter. Finally, BlackRock Fund Advisors raised its stake in Physicians Realty Trust by 28.6% in the third quarter. BlackRock Fund Advisors now owns 4,473,548 shares of the real estate investment trust’s stock worth $96,360,000 after buying an additional 995,055 shares during the last quarter. Institutional investors and hedge funds own 95.93% of the company’s stock.

Several equities analysts have recently weighed in on DOC shares. Zacks Investment Research downgraded Physicians Realty Trust from a “hold” rating to a “sell” rating in a research report on Tuesday, October 4th. BTIG Research started coverage on Physicians Realty Trust in a research report on Thursday, August 25th. They issued a “buy” rating and a $25.00 target price on the stock. Raymond James Financial Inc. upgraded Physicians Realty Trust from a “market perform” rating to a “strong-buy” rating and set a $22.00 target price on the stock in a research report on Monday, November 7th. They noted that the move was a valuation call. Citigroup Inc. downgraded Physicians Realty Trust from an “outperform” rating to a “market perform” rating in a research report on Friday, September 2nd. They noted that the move was a valuation call. Finally, Compass Point raised their target price on Physicians Realty Trust from $20.50 to $24.00 and gave the company a “buy” rating in a research report on Tuesday, August 9th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $20.93.

About Physicians Realty Trust

Physicians Realty Trust is a healthcare real estate company. The Company is engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company’s portfolio includes approximately 150 properties located in approximately 30 states with approximately 5,799,340 net leasable square feet.

5 Day Chart for NYSE:DOC

Receive News & Stock Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related stocks with our FREE daily email newsletter.